Abacavir Sulfate (188062-50-2): A Thorough Overview
Abacavir Base (CAS number 188062-50-2) is a significant medication typically utilized in the therapy of Human Immunodeficiency Virus (HIV) and related secondary infections . It functions as a nucleoside-like inhibitor , interfering with the HIV's replication cycle. Administered frequently in conjunction other antiretroviral agents , abacavir plays a key part in controlling the amount of virus and improving patient condition. Careful human leukocyte testing for the B5701 allele is necessary prior to start of abacavir's treatment to avoid the possibility of a severe reaction .
Abarelix (183552-38-7): Attributes and Uses
Abarelix, identified by the Substance Designation 183552-38-7, is a laboratory-created polypeptide antagonist of gonadotropin-releasing hormone (GnRH). The key characteristic lies in its ability to initially stimulate, then rapidly desensitize GnRH receptors, leading to a profound reduction in gonadotropin production . Therapeutically, abarelix is applied primarily in the therapy of advanced prostate disease; however, studies also explores possible applications in other hormonal disorders and reproductive issues. The agent's structure allows for targeted receptor connection.
```text
Abiraterone Acetate (154229-18-2): Synthesis and Analytical Data
The preparation of Abiraterone Acetate, identified by the Chemical Abstracts Service Registry Number 154229-18-2, involves detailed multistep chemical routes. Several described methods exist, often beginning with Androstadienedione and utilizing specific oxidation and acetylation steps. A typical method includes protecting group strategies to ensure desired regioselectivity. Analytical information, crucial for assurance control, routinely employs high-performance chromatography (HPLC) for measurement of impurities. Nuclear Magnetic Resonance (NMR) analysis confirms the structural identity. Mass spectrometry provides molecular weight validation. Other methods, like infrared (IR) analysis, assist in characterization and are critical for batch release.
- Production Routes
- Quality Control
- Analytical Characterization
```
```text
Understanding the CAS Numbers of Abacavir, Abarelix, and Abiraterone Acetate
Identifying chemical substances accurately is paramount in fields like medicine, research, and manufacturing. A crucial tool for this identification is the Chemical Abstracts Service (CAS) registry number – a unique numerical identifier assigned to every distinct chemical compound. Let's examine the CAS numbers for three significant pharmaceuticals: Abacavir, Abarelix, and Abiraterone Acetate. Familiarizing with these identifiers aids in precise referencing and prevents ambiguity within scientific literature and regulatory documentation. Abacavir, a nucleoside reverse transcriptase inhibitor used to treat HIV, holds the CAS number 60242-78-0. Abarelix, a gonadotropin-releasing hormone (GnRH) receptor antagonist employed in prostate cancer treatment, is identified by the CAS number 5490-02-9. Finally, Abiraterone a CYP17 inhibitor used in metastatic prostate cancer, possesses the CAS number 857342-50-7. Correctly utilizing these numbers ensures clarity and consistency when discussing these medications.
- The Antiretroviral CAS Number: 60242-78-0
- Compound B CAS Number: 5490-02-9
- Compound C CAS Number: 857342-50-7
```
Key Information on Abacavir Sulfate , Abarelix for Treatment, and Abiraterone
These drugs represent distinct treatments in medicine. Abacavir is ACETARSOL 97-44-9 a medicine primarily given to manage HIV illness, often with other medications. Abarelix for Treatment is a medication that works as a receptor blocker, typically prescribed to manage prostate tumors before surgery . Lastly, Abiraterone is another medication administered to treat advanced prostate growths, specifically targeting testosterone production . Always remember ask a healthcare professional for complete information and advice regarding any drug.
Medical Perspectives: Abacavir, Abarelix, Abiraterone Acetate and Their CAS Numbers
Reviewing key therapeutic compounds demands the clear recognition. Notably, Abacavir Sulfate, utilized in AIDS therapy, has a Registration Number of 3870-92-6. In the same way, Abarelix, a GnRH antagonist blocker administered in prostate tumors treatment, bears the CAS Identifier 64347-82-2. Lastly, Abiraterone Acetate, a compound in advanced testicular tumors, can be linked with the CAS Code 864930-63-3. The identifiers are essential resources to correct medicinal labeling & study.